4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-22-000212
CEO and CFO bought 2,050 shares at $23.82 ($48,831)
From the SEC's structured data for this filing
Trades in this filing
Patel Snehal · CEO and CFO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-01-03 | Purchase : show line 1 in the form | +2,050 | $23.82 | $48,831 | 1,193,429 | D |
| Open-market purchases · 2,050 sh · avg $23.82 · $48,831 | ||||||
Loading xslF345X03/ownership.xml…